Filing Details

Accession Number:
0000899243-19-012105
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-03 21:52:14
Reporting Period:
2019-05-01
Accepted Time:
2019-05-03 21:52:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1731831 Eidos Therapeutics Inc. EIDX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1655016 C Jonathan Fox C/O Eidos Therapeutics, Inc.
101 Montgomery Street, Suite 2550
San Francisco CA 94104
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-30 1,081 $12.01 1,081 No 5 A Direct
Common Stock Disposition 2019-05-01 1,108 $26.01 530,419 No 4 S Indirect See footnote
Common Stock Disposition 2019-05-01 3,892 $25.30 526,527 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. Shares acquired pursuant to the Issuer's 2018 Employee Stock Purchase Plan.
  2. The shares are held by Jonathan C Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014.